R. Leemans

An investigation into the crystallisation behaviour of an amorphous cryomilled pharmaceutical material above and below the glass transition temperature.

P. Belton, S. Qi, D. Craig, 2010, Journal of pharmaceutical sciences.

Etravirine: From TMC125 to Intelence: A Treatment Paradigm Shift for HIV‐Infected Patients

K. Andries, M. Kukla, J. Vingerhoets, 2011 .

Effects of Different Meal Compositions and Fasted State on the Oral Bioavailability of Etravirine

V. Vyncke, M. Boffito, A. Pozniak, 2008, Pharmacotherapy.

Pharmacokinetics and short-term safety and tolerability of etravirine in treatment-experienced HIV-1-infected children and adolescents

Christoph Königs, Claudio Viscoli, Susanna Esposito, 2012, AIDS.

Physicochemical properties of the amorphous drug, cast films, and spray dried powders to predict formulation probability of success for solid dispersions: etravirine.

Sheng Qi, Jody Voorspoels, Mike Reading, 2011, Journal of pharmaceutical sciences.

Single-dose pharmacokinetics of pediatric and adult formulations of etravirine and swallowability of the 200-mg tablet: results from three Phase 1 studies.

V. Vyncke, M. Peeters, T. Kakuda, 2013, International journal of clinical pharmacology and therapeutics.